Implantable Cardiac Monitoring for Atrial Fibrillation Detection in Patients with Stroke: A Systematic Review and Meta-Analysis
NeuroSci · 19.07.2026 · 7 (4) · 83
DOI: 10.3390/neurosci7040083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NeuroSci, online erschienen am 19.07.2026. Verfasst von Nibras M Alkhamis und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is a common but frequently undiagnosed cause of ischemic stroke, particularly among patients with cryptogenic stroke and embolic stroke of undetermined source (ESUS). Implantable cardiac monitors (ICMs) enable prolonged continuous rhythm monitoring and may improve AF detection following ischemic stroke or transient ischemic attack (TIA). This systematic review and meta-analysis aimed to evaluate the diagnostic yield, clinical impact, and safety of prolonged ICM monitoring in patients with ischemic stroke or TIA.
Methods
This systematic review and meta-analysis was conducted in accordance with the PRISMA 2020 guidelines and registered with PROSPERO (CRD42024573913). PubMed, Google Scholar, and the Cochrane Library were systematically searched. Randomized controlled trials and observational studies evaluating the use of ICMs after ischemic stroke or TIA were included. Randomized evidence was synthesized narratively, whereas single-arm random-effects meta-analyses of observational studies were performed to estimate pooled proportions for AF detection, oral anticoagulation initiation, recurrent ischemic stroke or TIA, and device-related adverse events.
Results
Twelve completed studies involving 4563 participants met the inclusion criteria, including two randomized controlled trials and ten observational studies. One additional ongoing randomized controlled trial (Find-AF 2) involving a planned enrollment of 5200 participants was identified and is described narratively. Across the observational studies, the pooled AF detection rate during prolonged ICM monitoring was 25.9% (95% CI, 18.9–33.5%), although substantial heterogeneity was observed (I2 = 95%). Oral anticoagulation was initiated in 94.2% (95% CI, 79.4–100.0%) of patients diagnosed with AF. Device-related complications were uncommon, with a pooled incidence of 3.7% (95% CI, 2.0–6.0%; I2 = 0%), while the pooled rate of recurrent ischemic stroke or TIA during follow-up was 6.2% (95% CI, 3.9–9.2%). Narrative synthesis of the randomized evidence demonstrated that ICMs significantly increased AF detection compared with conventional monitoring but did not demonstrate a significant reduction in recurrent stroke during the available follow-up period.
Conclusions
Prolonged implantable cardiac monitoring identifies AF in approximately one-quarter of patients following ischemic stroke or TIA and frequently leads to the initiation of oral anticoagulation, with a favorable safety profile. Although ICMs substantially improve AF detection, current evidence remains insufficient to confirm that increased detection translates into a reduction in recurrent stroke. Large, adequately powered randomized controlled trials are needed to determine the long-term clinical benefits of ICM-guided management and to define the optimal monitoring strategy for patients following ischemic stroke.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, King Faisal University, Al Ahsa 31982, Saudi Arabia.
- General Medicine Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah 21423, Saudi Arabia.
- College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
- College of Medicine, King Abdulaziz University, Jeddah 23452, Saudi Arabia.
- College of Medicine, Fakeeh College for Medical Sciences, Jeddah 23323, Saudi Arabia.
ORCID-Profile: Lujeen H Alghourab, Saud A Alnaaim
Zitieren
APA
Alkhamis, N. M., Almohammed, H. A., Khan, T. N., Alzahrani, J. H., Alsalboud, L. A., Alzahrani, R. T., Alseni, H. A., Mufti, A. M., Alghourab, L. H., Abuhaimed, T. F., Alshabaan, M. M., Alsubaie, M. E., Jamlalail, M. A., & Alnaaim, S. A. (2026). Implantable Cardiac Monitoring for Atrial Fibrillation Detection in Patients with Stroke: A Systematic Review and Meta-Analysis. NeuroSci, 7(4), 83. https://doi.org/10.3390/neurosci7040083
Vancouver
Alkhamis NM, Almohammed HA, Khan TN, Alzahrani JH, Alsalboud LA, Alzahrani RT, et al. Implantable Cardiac Monitoring for Atrial Fibrillation Detection in Patients with Stroke: A Systematic Review and Meta-Analysis. NeuroSci. 2026;7(4):83. doi:10.3390/neurosci7040083
BibTeX
@article{Alkhamis2026,
author = {Alkhamis, Nibras M and Almohammed, Hussain A and Khan, Tanveer N and Alzahrani, Jory H and Alsalboud, Lama A and Alzahrani, Randah T and Alseni, Hamad A and Mufti, Amara M and Alghourab, Lujeen H and Abuhaimed, Thekra F and Alshabaan, Manar M and Alsubaie, Maha E and Jamlalail, Manar A and Alnaaim, Saud A},
title = {Implantable Cardiac Monitoring for Atrial Fibrillation Detection in Patients with Stroke: A Systematic Review and Meta-Analysis},
journal = {NeuroSci},
year = {2026},
volume = {7},
number = {4},
pages = {83},
doi = {10.3390/neurosci7040083}
}
EUVIMED